DE68922932D1 - Hohe Expression von Proteinen in Hefe. - Google Patents

Hohe Expression von Proteinen in Hefe.

Info

Publication number
DE68922932D1
DE68922932D1 DE68922932T DE68922932T DE68922932D1 DE 68922932 D1 DE68922932 D1 DE 68922932D1 DE 68922932 T DE68922932 T DE 68922932T DE 68922932 T DE68922932 T DE 68922932T DE 68922932 D1 DE68922932 D1 DE 68922932D1
Authority
DE
Germany
Prior art keywords
yeast
proteins
high expression
adr
regulatory sequences
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE68922932T
Other languages
English (en)
Other versions
DE68922932T2 (de
Inventor
Jeffrey R Shuster
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Vaccines and Diagnostics Inc
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Corp filed Critical Chiron Corp
Application granted granted Critical
Publication of DE68922932D1 publication Critical patent/DE68922932D1/de
Publication of DE68922932T2 publication Critical patent/DE68922932T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]
    • C07K14/503—Fibroblast growth factor [FGF] basic FGF [bFGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DE68922932T 1988-05-06 1989-04-28 Hohe Expression von Proteinen in Hefe. Expired - Lifetime DE68922932T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19086888A 1988-05-06 1988-05-06

Publications (2)

Publication Number Publication Date
DE68922932D1 true DE68922932D1 (de) 1995-07-13
DE68922932T2 DE68922932T2 (de) 1995-10-19

Family

ID=22703135

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68922932T Expired - Lifetime DE68922932T2 (de) 1988-05-06 1989-04-28 Hohe Expression von Proteinen in Hefe.

Country Status (8)

Country Link
US (1) US6183985B1 (de)
EP (1) EP0340986B1 (de)
JP (4) JP3074174B2 (de)
AT (1) ATE123521T1 (de)
CA (1) CA1324969C (de)
DE (1) DE68922932T2 (de)
DK (1) DK175898B1 (de)
ES (1) ES2072900T3 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0801682T3 (da) 1995-02-09 2002-02-18 Aventis Pharma Gmbh Fremgangsmåde til fremstilling af proteiner
DE19544233A1 (de) * 1995-11-28 1997-06-05 Hoechst Ag Verfahren zur Nutzung des Hefe-ADH II-Promotorsystems zur biotechnologischen Produktion heterologer Proteine in hohen Ausbeuten
WO2003027280A1 (fr) * 2001-09-20 2003-04-03 Toyota Jidosha Kabushiki Kaisha Systeme de surexpression genique
KR20070007086A (ko) 2004-02-02 2007-01-12 암브룩스, 인코포레이티드 변형된 인간의 4 개의 나선형 다발 폴리펩티드 및 이의용도
BRPI0512235A (pt) * 2004-06-18 2008-02-19 Ambrx Inc polipeptìdeos ligadores de antìgenos e seus usos
CA2569381A1 (en) * 2004-07-21 2006-08-31 Ambrx, Inc. Biosynthetic polypeptides utilizing non-naturally encoded amino acids
CA2594557C (en) * 2004-12-22 2016-04-26 Ambrx, Inc. Modified human growth hormone
AU2005319518B2 (en) * 2004-12-22 2010-09-09 Ambrx, Inc. Compositions of aminoacyl-tRNA synthetase and uses thereof
NZ555386A (en) 2004-12-22 2011-01-28 Ambrx Inc Formulations of human growth hormone comprising a non-naturally encoded amino acid
GB2438760A (en) * 2004-12-22 2007-12-05 Ambrx Inc Methods for expression and purification of recombinant human growth hormone
CA3005835C (en) 2004-12-22 2023-01-31 Ambrx, Inc. Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
SG165353A1 (en) * 2005-06-03 2010-10-28 Ambrx Inc Improved human interferon molecules and their uses
DE102005029170A1 (de) * 2005-06-23 2006-12-28 Consortium für elektrochemische Industrie GmbH System zur Genexpression in Hefen der Gattung Sporidiobolus
CN102703446B (zh) 2005-08-18 2014-05-28 Ambrx公司 tRNA组合物和其用途
NZ567234A (en) * 2005-11-08 2011-09-30 Ambrx Inc Accelerants for the modification of non-natural amino acids and non-natural amino acid polypeptides
WO2007059312A2 (en) 2005-11-16 2007-05-24 Ambrx, Inc. Methods and compositions comprising non-natural amino acids
CA2630220C (en) 2005-11-22 2020-10-13 Doris Coit Norovirus and sapovirus antigens
US9133495B2 (en) * 2006-09-08 2015-09-15 Ambrx, Inc. Hybrid suppressor tRNA for vertebrate cells
CN101511856B (zh) * 2006-09-08 2016-01-20 Ambrx公司 脊椎动物细胞中抑制因子trna的转录
AU2007292903B2 (en) * 2006-09-08 2012-03-29 Ambrx, Inc. Modified human plasma polypeptide or Fc scaffolds and their uses
EP2106447B1 (de) * 2007-01-26 2013-04-17 Novozymes A/S Verfahren zur methanolunabhängigen einführung methanolinduzierbarer promotoren in pichia
KR20140012199A (ko) 2007-03-30 2014-01-29 암브룩스, 인코포레이티드 변형된 ｆｇｆ-21 폴리펩티드 및 그 용도
NZ580686A (en) 2007-05-02 2012-11-30 Ambrx Inc Modified interferon beta polypeptides and their uses
ES2632504T3 (es) 2007-11-20 2017-09-13 Ambrx, Inc. Polipéptidos de insulina modificados y sus usos
NZ602170A (en) 2008-02-08 2014-03-28 Ambrx Inc Modified leptin polypeptides and their uses
EP2300615A2 (de) * 2008-07-11 2011-03-30 Novozymes A/S Das-promotervarianten aus pichia pastoris
NZ600382A (en) 2008-07-23 2013-11-29 Ambrx Inc Modified bovine G-CSF polypeptides and their uses
WO2010036964A2 (en) 2008-09-26 2010-04-01 Ambrx Inc. Modified animal erythropoietin polypeptides and their uses
ES2660000T3 (es) 2008-09-26 2018-03-20 Ambrx, Inc. Vacunas y microorganismos dependientes de la replicación de aminoácidos no naturales
EP2805965A1 (de) 2009-12-21 2014-11-26 Ambrx, Inc. Modifizierte Schweine-Somatotropin-Polypeptide und deren Verwendungen
CN102753573A (zh) 2009-12-21 2012-10-24 Ambrx公司 经过修饰的牛促生长素多肽和其用途
EP2591097A1 (de) 2010-07-06 2013-05-15 Novartis AG Immunogene zusammensetzungen aus norovirus und verfahren
PL2605789T3 (pl) 2010-08-17 2019-11-29 Ambrx Inc Zmodyfikowane polipeptydy relaksyny i ich zastosowania
US9567386B2 (en) 2010-08-17 2017-02-14 Ambrx, Inc. Therapeutic uses of modified relaxin polypeptides
TWI480288B (zh) 2010-09-23 2015-04-11 Lilly Co Eli 牛顆粒細胞群落刺激因子及其變體之調配物
CA2965502A1 (en) 2014-10-24 2016-04-28 Bristol-Myers Squibb Company Modified fgf-21 polypeptides and uses thereof
MX2019008449A (es) 2017-02-08 2019-09-09 Bristol Myers Squibb Co Polipetidos de relaxina modificada que comprenden un mejorador farmacocinetico y sus usos.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4880734A (en) * 1984-05-11 1989-11-14 Chiron Corporation Eukaryotic regulatable transcription
EP0196056B1 (de) * 1985-03-28 1991-05-22 Chiron Corporation Expression durch Verwendung von Fusionsgenen für Proteinproduktion
EP0234871A3 (de) 1986-02-28 1988-10-12 Merck & Co. Inc. Regulierbare Expression rekombinanter Proteine in Hefe
US5068185A (en) 1986-07-10 1991-11-26 Merck & Co., Inc. Trains of yeast for the expression of heterologous genes

Also Published As

Publication number Publication date
EP0340986B1 (de) 1995-06-07
JP3484386B2 (ja) 2004-01-06
JP3561513B2 (ja) 2004-09-02
JPH02104291A (ja) 1990-04-17
DE68922932T2 (de) 1995-10-19
ES2072900T3 (es) 1995-08-01
DK221589D0 (da) 1989-05-05
CA1324969C (en) 1993-12-07
DK221589A (da) 1989-11-07
JP2000300277A (ja) 2000-10-31
JP2003116525A (ja) 2003-04-22
EP0340986A3 (de) 1991-07-31
US6183985B1 (en) 2001-02-06
JP2004081222A (ja) 2004-03-18
DK175898B1 (da) 2005-05-30
ATE123521T1 (de) 1995-06-15
JP3074174B2 (ja) 2000-08-07
EP0340986A2 (de) 1989-11-08

Similar Documents

Publication Publication Date Title
ATE123521T1 (de) Hohe expression von proteinen in hefe.
KR870007282A (ko) 효모에서 b형 간염 바이러스 단백질을 제조하는 방법
DE68913590D1 (de) Verbrennungsverfahren eines Ofens.
DE3763968D1 (de) Ester von thiolcarboxylsaeuren.
DE68920374T2 (de) Rechnergestützte Einstellung von Turbinensteuerungen.
DE68928380T2 (de) Expression von menschlichen Serumalbumin in methylotrophischen Hefen
AU599943B2 (en) Fusion proteins with a eukaryotic ballast portion
FI90667C (fi) Menetelmä valmistaa uutta ihmisen tyypin I interferoniproteiinia
AU4764385A (en) Method for silver staining proteins and nucleic acids
BR8706479A (pt) Processo de queima de combustivel hidrocarbonico com controle das emissoes de sulfuroxidos
DK0466963T3 (da) Fremgangsmåde til fremstilling af alfa-L-aspartyl-L-phenyl-alaninmethylester, hydroclorid ved anvend else af isoleret N-formyl-asparaginsyreanhydrid
ES2060392T3 (es) Nueva region promotora.
DK391185D0 (da) Rekombinant saccharomyces
NO891687D0 (no) Ekspresjon av hepatitt-b pres2-protein i metylotrofe gjaersorter.
DE68920562T2 (de) Isomerisierung von Carbonsäuren.
DE68910029D1 (de) Ester-Derivat von Phenylbicyclohexanol.
DE68915248D1 (de) Unterscheidung von Bildbereichen.
NO903244L (no) Styring for gassutladningslamper.
NO893070D0 (no) Fremgangsmaate ved solubilisering.
DE68905188T2 (de) Fermentationsprozess fuer carboxylsaeuren.
DE3881321D1 (de) Octapeptide als hemmer myristoylierender enzyme.
BR8801047A (pt) Economizador de combustivel
BR8801079A (pt) Economizador de combustivel

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: NOVARTIS VACCINES AND DIAGNOSTICS,INC.(N.D.GES, US